Resources
Principal content
Cancer drug setback hits Antisoma
Shares in Antisoma fell almost 71 per cent following news that one of its key cancer drugs did not prolong life in humans
GSK seeks to work with Japanese SMEs
GlaxoSmithKline is seeking small and medium-sized Japanese pharmaceutical companies either to invest in or to collaborate with to develop drugs and to facilitate global distribution once they come to market
Europe halts sale of Indian-sourced drug
The European Medicines Agency recalls eight separate generic versions of clopidogrel, used to stop blood clots, in a move that raises concerns about low-cost medicines from the country
SSL eyes buoyant sales despite weaker UK
The personal goods group says recent acquisitions of condom businesses in eastern Europe, combined with continued demand for Scholl footwear in Japan and France will buoy full-year sales
Brown starts agency to export medical skills
Gordon Brown gave a final pre-electoral fillip to healthcare on Thursday with plans to sell the National Health Service’s skills abroad and invest in medical research at home.
FuturaGene investors caught up in UK swoop
Two of the seven suspects arrested in a high-profile insider dealing crackdown are among the biotechnology company’s biggest shareholders
GSK and Pfizer pledge vaccines
GlaxoSmithKline and Pfizer could share up to $1.5bn from deeply discounted sales of their pneumococcal vaccines to the world’s poorest countries as part of a pioneering project
John Kay: How to make money without trying
James Black, inventor of beta-blockers, created more shareholder value than any other European in the post-war period. But this was no part of his intention, writes John Kay
Locums languish after accounting switch
Recruitment agency’s shares fall 25% after new accounting policies leave 2009 pre-tax profits well below City expectations
Impurities to hit GSK vaccine sales
The UK-based pharmaceutical company is set to lose more than one month’s sales of its Rotarix vaccine against gastroenteritis in the US after impurities in the product were discovered
Related content and features
Track this Topic
Recent drugs and healthcare reports
Market research reports
Report name | Author | Publish date | Cost |
---|---|---|---|
The Worldwide Market for Cancer Diagnostics, 4th Edition | Kalorama Information | 4/1/2010 | $4200 |
The World Anesthesia Drug Market | Kalorama Information | 4/1/2010 | $3995 |
The Market for Prescription Dermatological Drugs, 7th Edition | Kalorama Information | 4/1/2010 | $3990 |
The Future of Blood Disorders Therapeutics, Analysis and Market Forecasts to 2016 - Better and More Cost-Effective Treatment Options Create Opportunities | GBI Research | 3/25/2010 | $3500 |
The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges | GBI Research | 3/25/2010 | $3500 |